Advertisement

Index by Author

July 2000; 49 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Accili, D

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  2. Adachi, T

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  3. Aida, K

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  4. Ainscow, E K

    • Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes July 2000 49:1149-1155; doi:10.2337/diabetes.49.7.1149

  5. Alford, F

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  6. Alleva, D G

    • Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes July 2000 49:1106-1115; doi:10.2337/diabetes.49.7.1106

  7. Amadio, L

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  8. Andersen, J L

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  9. Aust, G

    • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes July 2000 49:1137-1141; doi:10.2337/diabetes.49.7.1137

B

  1. Bagstaff, S M

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

  2. Ban, N

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  3. Baron, A D

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  4. Båvenholm, P N

    • Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes July 2000 49:1078-1083; doi:10.2337/diabetes.49.7.1078

  5. Beck-Nielsen, H

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  6. Beguinot, F

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  7. Beller, D I

    • Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes July 2000 49:1106-1115; doi:10.2337/diabetes.49.7.1106

  8. Björk, E

    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  9. Bolli, G B

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  10. Bradley, R L

    • Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes. Diabetes July 2000 49:1073-1077; doi:10.2337/diabetes.49.7.1073

  11. Burger, A G

    • Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes July 2000 49:1101-1105; doi:10.2337/diabetes.49.7.1101

  12. Burguera, B

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

C

  1. Capaldo, B

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  2. Carmona, M C

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  3. Caruso, M

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  4. Cersosimo, E

    • Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes July 2000 49:1186-1193; doi:10.2337/diabetes.49.7.1186

  5. Cheatham, B

    • Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes. Diabetes July 2000 49:1073-1077; doi:10.2337/diabetes.49.7.1073

  6. Chen, J

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  7. Chen, M C

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116

  8. Chiarelli, F

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  9. Chou, E

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  10. Cipollone, F

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  11. Cleary, M P

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

  12. Condorelli, G

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  13. Costantini, F

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  14. Couce, M E

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

  15. Cronin, J

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  16. Croset, M

    • Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes July 2000 49:1165-1168; doi:10.2337/diabetes.49.7.1165

  17. Crowder, K

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  18. Cuccurullo, F

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  19. Curran, G L

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

  20. Cusin, I

    • Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes July 2000 49:1101-1105; doi:10.2337/diabetes.49.7.1101

D

  1. Daugaard, J R

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  2. Dietrich, A D

    • Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites. Diabetes July 2000 49:1096-1100; doi:10.2337/diabetes.49.7.1096

  3. Di Mario, U

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  4. di Ricco, L

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

E

  1. Edwards, C L

    • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes July 2000 49:1203-1208; doi:10.2337/diabetes.49.7.1203

  2. Efendic, S

    • Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes July 2000 49:1078-1083; doi:10.2337/diabetes.49.7.1078

  3. Eizirik, D L

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116

F

  1. Ferretti, J

    • Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes July 2000 49:1186-1193; doi:10.2337/diabetes.49.7.1186

  2. Fiory, F

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  3. Flodström, M

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116

  4. Formisano, P

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

G

  1. Gabriele, A

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  2. Garlick, P

    • Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans. Diabetes July 2000 49:1186-1193; doi:10.2337/diabetes.49.7.1186

  3. Giralt, M

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  4. Gradini, R

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  5. Grant, C

    • Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes July 2000 49:1106-1115; doi:10.2337/diabetes.49.7.1106

H

  1. Hansen, J B

    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  2. Hargreaves, M

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  3. Ha, S W

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  4. Hayashi, J I

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  5. Henriksen, J E

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  6. Holmäng, A

    • Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes July 2000 49:1178-1185; doi:10.2337/diabetes.49.7.1178

  7. Holst, J J

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  8. Holz, G G

    • Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes July 2000 49:1156-1164; doi:10.2337/diabetes.49.7.1156

  9. Hook, G

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  10. Hother-Nielsen, O

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  11. Hussain, M A

    • Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes July 2000 49:1156-1164; doi:10.2337/diabetes.49.7.1156

I

  1. Iacobini, C

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  2. Iglesias, R

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  3. Ihara, Y

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  4. Inada, A

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  5. Isobe, K

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  6. Iwakura, T

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

J

  1. Jackson, S

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

  2. Jensen, M D

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

K

  1. Karlsen, A E

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  2. Karlsson, F A

    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  3. Kaser, S B

    • Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes July 2000 49:1106-1115; doi:10.2337/diabetes.49.7.1106

  4. Kemppainen, J

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  5. King, G L

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  6. Kocova, M

    • Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes July 2000 49:1264-1268; doi:10.2337/diabetes.49.7.1264

  7. Kokkotou, E G

    • Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes. Diabetes July 2000 49:1073-1077; doi:10.2337/diabetes.49.7.1073

  8. Kristiansen, S

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  9. Kubota, A

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  10. Kullin, M

    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  11. Kuroe, A

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

L

  1. Larmola, K

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  2. Lenti, L

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  3. Lenzen, S

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  4. Leto, G

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  5. Levin, K

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  6. Liu, D

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116

  7. Liu, F T

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  8. Li, Z

    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  9. Lloyd, R V

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

  10. Lönnroth, P

    • Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes July 2000 49:1178-1185; doi:10.2337/diabetes.49.7.1178

  11. Lortz, S

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  12. Lynn, S

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

M

  1. Mampel, T

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  2. Maratos-Flier, E

    • Melanin-concentrating hormone regulates leptin synthesis and secretion in rat adipocytes. Diabetes July 2000 49:1073-1077; doi:10.2337/diabetes.49.7.1073

  3. Marini, M

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  4. Meier, M

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  5. Mezzetti, A

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  6. Miele, C

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  7. Mithieux, G

    • Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes July 2000 49:1165-1168; doi:10.2337/diabetes.49.7.1165

  8. Miyawaki, K

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  9. Montano, S

    • Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes July 2000 49:1165-1168; doi:10.2337/diabetes.49.7.1165

  10. Murthy, S

    • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes July 2000 49:1203-1208; doi:10.2337/diabetes.49.7.1203

N

  1. Nachtwey, T

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  2. Naruse, K

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  3. Nerup, J

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  4. Nguyen, T B

    • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes July 2000 49:1137-1141; doi:10.2337/diabetes.49.7.1137

  5. Nielsen, J N

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  6. Niklasson, M

    • Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes July 2000 49:1178-1185; doi:10.2337/diabetes.49.7.1178

  7. Nuutila, P

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

O

  1. O'Rahilly, S

    • Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes July 2000 49:1264-1268; doi:10.2337/diabetes.49.7.1264

  2. Ohkubo, E

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  3. Ohtaka, M

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  4. Oikonen, V

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  5. Oksanen, A

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  6. Oliva, A

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  7. Onaya, T

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  8. Oriente, F

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

P

  1. Paradisi, G

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  2. Park, J Y

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  3. Pavlovic, D

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116

  4. Pavlovich, R P

    • Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes July 2000 49:1106-1115; doi:10.2337/diabetes.49.7.1106

  5. Pedraza, N

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  6. Peltoniemi, P

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  7. Petro, A E

    • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes July 2000 49:1203-1208; doi:10.2337/diabetes.49.7.1203

  8. Pierdomenico, S D

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  9. Pigon, J

    • Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes July 2000 49:1078-1083; doi:10.2337/diabetes.49.7.1078

  10. Poduslo, J F

    • Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes July 2000 49:1219-1223; doi:10.2337/diabetes.49.7.1219

  11. Pomilio, M

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  12. Pricci, F

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  13. Pugliese, G

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

R

  1. Rajas, F

    • Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes July 2000 49:1165-1168; doi:10.2337/diabetes.49.7.1165

  2. Rau, H

    • Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes July 2000 49:1264-1268; doi:10.2337/diabetes.49.7.1264

  3. Rhodes, C J

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  4. Riccardi, G

    • The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes July 2000 49:1194-1202; doi:10.2337/diabetes.49.7.1194

  5. Richter, E A

    • Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes July 2000 49:1092-1095; doi:10.2337/diabetes.49.7.1092

  6. Roach, P J

    • Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites. Diabetes July 2000 49:1096-1100; doi:10.2337/diabetes.49.7.1096

  7. Rohner-Jeanrenaud, F

    • Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes July 2000 49:1101-1105; doi:10.2337/diabetes.49.7.1101

  8. Romano, F

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  9. Romeo, G

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  10. Rouru, J

    • Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes July 2000 49:1101-1105; doi:10.2337/diabetes.49.7.1101

  11. Ruderman, N B

    • Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes July 2000 49:1078-1083; doi:10.2337/diabetes.49.7.1078

  12. Ruotsalainen, U

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  13. Rutter, G A

    • Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes July 2000 49:1149-1155; doi:10.2337/diabetes.49.7.1149

S

  1. Saha, A K

    • Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes July 2000 49:1078-1083; doi:10.2337/diabetes.49.7.1078

  2. Sale, P

    • The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression. Diabetes July 2000 49:1249-1257; doi:10.2337/diabetes.49.7.1249

  3. Sandler, S

    • Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes July 2000 49:1116-1122; doi:10.2337/diabetes.49.7.1116
    • K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin. Diabetes July 2000 49:1131-1136; doi:10.2337/diabetes.49.7.1131

  4. Scherbaum, W A

    • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes July 2000 49:1137-1141; doi:10.2337/diabetes.49.7.1137

  5. Seino, Y

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  6. Seissler, J

    • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes July 2000 49:1137-1141; doi:10.2337/diabetes.49.7.1137

  7. Shen, Z P

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  8. Sipilä, H

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  9. Sjöstrand, M

    • Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes July 2000 49:1178-1185; doi:10.2337/diabetes.49.7.1178

  10. Skoglund, G

    • Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes July 2000 49:1156-1164; doi:10.2337/diabetes.49.7.1156

  11. Skurat, A V

    • Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites. Diabetes July 2000 49:1096-1100; doi:10.2337/diabetes.49.7.1096

  12. Solanes, G

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  13. Someya, Y

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  14. Steinberg, H O

    • Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes July 2000 49:1231-1238; doi:10.2337/diabetes.49.7.1231

  15. Steinbrenner, H

    • Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. Diabetes July 2000 49:1137-1141; doi:10.2337/diabetes.49.7.1137

  16. Strindberg, L

    • Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects. Diabetes July 2000 49:1178-1185; doi:10.2337/diabetes.49.7.1178

  17. Sunaga, Y

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  18. Surwit, R S

    • Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice. Diabetes July 2000 49:1203-1208; doi:10.2337/diabetes.49.7.1203

  19. Suzuma, K

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

T

  1. Takahara, N

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  2. Takala, T

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

  3. Tawata, M

    • A new mitochondrial DNA mutation at 14577 T/C is probably a major pathogenic mutation for maternally inherited type 2 diabetes. Diabetes July 2000 49:1269-1272; doi:10.2337/diabetes.49.7.1269

  4. Thye-Rønn, P

    • Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Diabetes July 2000 49:1209-1218; doi:10.2337/diabetes.49.7.1209

  5. Tiedge, M

    • Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes July 2000 49:1123-1130; doi:10.2337/diabetes.49.7.1123

  6. Toyokuni, S

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  7. Tsuda, K

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  8. Tsukiyama, K

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  9. Tumini, S

    • Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes July 2000 49:1258-1263; doi:10.2337/diabetes.49.7.1258

  10. Turnbull, D M

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

V

  1. Vazquez, M

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  2. Villarroya, F

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  3. Viñas, O

    • Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Diabetes July 2000 49:1224-1230; doi:10.2337/diabetes.49.7.1224

  4. Visser, T

    • Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes July 2000 49:1101-1105; doi:10.2337/diabetes.49.7.1101

W

  1. Walker, M

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

  2. Watanabe, R

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  3. Whitehead, J P

    • Naturally occurring amino acid substitutions at Arg1174 in the human insulin receptor result in differential effects on receptor biosynthesis and hybrid formation, leading to discordant clinical phenotypes. Diabetes July 2000 49:1264-1268; doi:10.2337/diabetes.49.7.1264

Y

  1. Yamada, Y

    • Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression. Diabetes July 2000 49:1142-1148; doi:10.2337/diabetes.49.7.1142

  2. Yamauchi, T

    • Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes July 2000 49:1239-1248; doi:10.2337/diabetes.49.7.1239

  3. Yeaman, S J

    • Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes July 2000 49:1169-1177; doi:10.2337/diabetes.49.7.1169

  4. Yki-Järvinen, H

    • Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. Diabetes July 2000 49:1084-1091; doi:10.2337/diabetes.49.7.1084

Z

  1. Zhao, C

    • Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes July 2000 49:1149-1155; doi:10.2337/diabetes.49.7.1149

  2. Zitoun, C

    • Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes July 2000 49:1165-1168; doi:10.2337/diabetes.49.7.1165

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement